3 research outputs found
Synthesis, Characterization, X‑ray Crystal Structure, DFT Calculations, and Catalytic Properties of a Dioxidovanadium(V) Complex Derived from Oxamohydrazide and Pyridoxal: A Model Complex of Vanadate-Dependent Bromoperoxidase
A vanadiumÂ(V) complex with the formula
[Et<sub>3</sub>NH]Â[V<sup>V</sup>O<sub>2</sub>(sox-pydx)] with a new
tridentate ligand 2-[2-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]Âmethylene]Âhydrazinyl]-2-oxoacetamide
(soxH-pydxH), obtained by condensation of oxamohydrazide and pyridoxal
(one of the forms of vitamin B<sub>6</sub>), has been synthesized.
The compound was characterized by various analytical and spectroscopic
methods, and its structure was determined by single-crystal X-ray
diffraction technique. Density functional theory (DFT) and time-dependent
DFT calculations were used to understand the electronic structure
of the complex and nature of the electronic transitions observed in
UV–vis spectra. In the complex, vanadiumÂ(V) is found to be
pentacoordinated with two oxido ligands and a bianionic tridentate
ONO-donor ligand. The vanadium center has square-pyramidal geometry
with an axial oxido ligand, and the equatorial positions are occupied
by another oxido ligand and a phenolato oxygen, an imine nitrogen,
and a deprotonated amide oxygen of the hydrazone ligand. A DFT-optimized
structure of the complex shows very similar metrical parameters as
determined by X-ray crystallography. The O<sub>4</sub>N coordination
environment of vanadium and the hydrogen-bonding abilities of the
pendant amide moiety have a strong resemblance with the vanadium center
in bromoperoxidase enzyme. Bromination experiments using H<sub>2</sub>O<sub>2</sub> as the oxidizing agent, with model substrate phenol
red, and the vanadium complex as a catalyst show a remarkably high
value of <i>k</i><sub>cat</sub> equal to 26340 h<sup>–1</sup>. The vanadium compound also efficiently catalyzes bromination of
phenol and salicylaldehyde as well as oxidation of benzene to phenol
by H<sub>2</sub>O<sub>2</sub>
The plant alkaloid chelerythrine binds to chromatin, alters H3K9Ac and modulates global gene expression
<p>Chelerythrine (CHL), a plant alkaloid, possesses antimicrobial, anti-inflammatory, and antitumor properties. Although CHL influences several key signal transduction pathways, its ability to interact directly with nucleoprotein complex chromatin, in eukaryotic cells has so far not been looked into. Here we have demonstrated its association with hierarchically assembled chromatin components, viz. long chromatin, chromatosome, nucleosome, chromosomal DNA, and histone H3 and the consequent effect on chromatin structure. CHL was found to repress acetylation at H3K9. It is more target-specific in terms of gene expression alteration and less cytotoxic compared to its structural analog sanguinarine.</p
DNA Damage and Apoptosis Induction in Cancer Cells by Chemically Engineered Thiolated Riboflavin Gold Nanoassembly
Herein we have engineered
a smart nuclear targeting thiol-modified riboflavin-gold nano assembly, <b>RfS@AuNPs</b>, which accumulates selectively in the nucleus without
any nuclear-targeting peptides (NLS/RGD) and shows photophysically
in vitro DNA intercalation. A theoretical model using Molecular Dynamics
has been developed to probe the mechanism of formation and stability
as well as dynamics of the <b>RfS@AuNPs</b> in aqueous solution
and within the DNA microenvironment. The <b>RfS@AuNPs</b> facilitate
the binucleated cell formation that is reflected in the significant
increase of DNA damage marker, Îł-H2AX as well as the arrest
of most of the HeLa cells at the pre-G1 phase indicating cell death.
Moreover, a significant upregulation of apoptotic markers confirms
that the cell death occurs through the apoptotic pathway. Analyses
of the microarray gene expression of <b>RfS@AuNPs</b> treated
HeLa cells show significant alterations in vital biological processes
necessary for cell survival. Taken together, our study reports a unique
nuclear targeting mechanism through targeting the riboflavin receptors,
which are upregulated in cancer cells and induce apoptosis in the
targeted cells